Our results further reveal that TFAP2C promotes CSCs characteristics and chemoresistance via transcriptionally activating negative regulators of Hippo signaling, ROCK1 and ROCK2, resulting in inactivation of Hippo signaling in CRC cells. Here, ROCK1 is linked to colorectal carcinoma.